Saeed Ahmed Memon: Can Hydralazine Stop Aggressive Brain Cancer Cells?
Saeed Ahmed Memon, Psychiatrist at Health Department Govt of SINDH Pakistan, shared a post on LinkedIn:
“Medical researchers at the University of Pennsylvania have recently unlocked the precise molecular secrets of Hydralazine, a cardiovascular medication that has been utilized globally for decades.
Scientists discovered that this established drug fundamentally works by blocking a specific oxygen-sensing enzyme known as ADO, which typically signals blood vessels to severely constrict when oxygen levels drop.
By actively shutting down this specific enzyme, the medication stabilizes cellular proteins and forces blood vessels to relax.
However, while mapping this exact cardiovascular mechanism, researchers stumbled upon an incredible secondary application regarding one of the most notoriously aggressive forms of brain cancer.
The exact oxygen-sensing pathway that constricts blood vessels is identically utilized by Glioblastoma tumors to survive and thrive in low-oxygen environments.
When scientists applied Hydralazine to these malignant cells, the medication did not kill them directly, but instead trapped the cancer in a dormant, non-dividing state known as senescence, abruptly halting the tumor’s growth.
This remarkable scientific breakthrough highlights the massive, untapped potential of repurposing established, safety-tested pharmaceutical compounds to combat highly complex oncological challenges.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 16:35Sultan Aydın Aslantaş: A Rare Coexistence of LAHPS and Bloom Syndrome in a Child
-
Nov 14, 2026, 16:27Nicolas Moniotte: Dual-Platform Gene Editing for Haemophilia A
-
Nov 14, 2026, 15:30Patient Selection for Gene Therapy in Transfusion-Dependent β-Thalassemia – EHA
-
Nov 14, 2026, 15:07Vaidehi Prasanth: Patient Blood Management in Hematological Patients A New Book Chapter
-
Nov 14, 2026, 15:00Ram Mohan Jaiswal: International Collaboration in Transfusion Medicine Through the Trans Med Africa Consortium
-
Nov 14, 2026, 14:48Jamie Sin Ying Ho: Stopping Anticoagulation After AF Ablation and Rhythm Control
-
Nov 14, 2026, 14:29Satya Prakash: Cell-Free Hemoglobin-Based Oxygen Carriers and Their Clinical Development
-
Nov 14, 2026, 14:24Adela Castro: Distinguishing Antiphospholipid Antibodies From APS in Pregnancy
-
Nov 14, 2026, 14:20Uzima Chirwa: Rethinking Comprehensive Care for Bleeding Disorders in Africa